We have located links that may give you full text access.
Utility of (111)In-Cl3 scintigraphy for differentiating bone marrow reconversion.
Journal of Nuclear Medicine Technology 2017 November 11
Indium chloride ((111)In-Cl3) scintigraphy has been used to evaluate various hematological diseases for many years. However, there have been few reports on patients with bone marrow reconversion showing high uptake in (111)In-Cl3 scintigraphy. Herein, we report a case of a 68-year-old man with esophageal cancer who underwent (18)F-FDG PET/CT for staging of the disease. (18)F-FDG PET/CT demonstrated high uptake in the first lumbar vertebral body, which was difficult to distinguish bone metastasis and bone marrow reconversion. (111)In-Cl3 scintigraphy demonstrated specific findings with high uptake in the lesion, indicating bone marrow hyperplasia or reconversion.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app